Clinical features, aetiology and outcome of empyema in children in the north east of England

Eastham, K. M.; Freeman, R.; Kearns, A. M.; Eltringham, G.; Clark, J.; Leeming, J.; Spencer, D. A.
June 2004
Thorax;Jun2004, Vol. 59 Issue 6, p522
Academic Journal
Background: The incidence of empyema in children in the UK is increasing. The reason for this is unclear. A prospective study was undertaken to investigate the clinical features, aetiology, and outcome of cases of empyema and parapneumonic effusion presenting to a tertiary poediatric respiratory centre between February 1997 and August 2001. Method: Routine bacterial culture of blood and pleural fluid was performed for 47 cases. Forty three pleural fluid specimens, culture negative for pneumococcus, were analysed for pneumococccal DNA by real time polymerase chain reaction (PCR). Penicillin susceptibility was determined for DNA positive specimens using complementary PCR assay. Capsular serotype specific antigen detection was by enzyme immunoassay (EIA) using monoclonal antibodies to serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. Clinical data were obtained from patient notes, supplemented by a postal questionnaire. Results: The median (range) age of the patients was 5.6 (0.6-16.9) years and 70% were male. The median (range) duration of illness before referral to hospital was 5 (0-25) days. Forty five (96%) had received antibiotics before referral; 32 (68%) required decortication and eight (21%) thoracocentesis. Median postoperative stay was 4 days (2-8). Thirty two (75%) pneumococcal culture negative specimens were pneumococcal DNA positive; 17 (53%) of these were serotype 1. All were penicillin sensitive. Conclusions: Pneumococcus is the major pathogen in childhood empyema and serotype 1 is the prevalent serotype. This has implications for vaccine development and immunisation strategy as the current 7-valent pneumococcal conjugate vaccine does not protect against serotype 1.


Related Articles

  • Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Golubchik, Tanya; Brueggemann, Angela B; Street, Teresa; Gertz, Robert E; Spencer, Chris C A; Ho, Thien; Giannoulatou, Eleni; Link-Gelles, Ruth; Harding, Rosalind M; Beall, Bernard; Peto, Tim E A; Moore, Matthew R; Donnelly, Peter; Crook, Derrick W; Bowden, Rory // Nature Genetics;Mar2012, Vol. 44 Issue 3, p352 

    Streptococcus pneumoniae ('pneumococcus') causes an estimated 14.5 million cases of serious disease and 826,000 deaths annually in children under 5 years of age. The highly effective introduction of the PCV7 pneumococcal vaccine in 2000 in the United States provided an unprecedented opportunity...

  • Pneumococcal infection.  // World of Irish Nursing;Oct2004, Vol. 12 Issue 9, p48 

    Presents information on pneumococcal infection. Causes; Conditions associated with increased risk of serious pneumococcal disease; Symptoms; Administration of vaccinations.

  • Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia. De Schutter, Iris; Vergison, Anne; Tuerlinckx, David; Raes, Marc; Smet, Julie; Smeesters, Pierre R.; Verhaegen, Jan; Mascart, Françoise; Surmont, Filip; Malfroot, Anne // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Community-acquired pneumonia (CAP) is a major cause of morbidity in children. This study estimated the proportion of children with pneumococcal CAP among children hospitalised with CAP in Belgium and describes the causative serotype distribution after implementation of the 7-valent pneumococcal...

  • Does the Presence of Pneumococcal DNA in Middle-Ear Fluid Indicate Pneumococcal Etiology in Acute Otitis Media? Palmu, Arto A.; Saukkoriipi, P. Annila; Lahdenkari, Mika I.; Kuisma, Leena K.; Mäkelä, P. Helena; Kilpi, Terhi M.; Leinonen, Maija // Journal of Infectious Diseases;3/1/2004, Vol. 189 Issue 5, p775 

    Bacterial culture of middle-ear fluid (MEF), the standard for etiologic diagnosis of acute otitis media (AOM), has revealed Streptococcus pneumoniae (Pnc) to be a major pathogen responsible for one-third of AOM cases. In the present study, we compared the results of polymerase chain reaction...

  • Enfermedades neumocócicas en niños. presentación clínica y tratamiento.  // Revista de la Facultad de Medicina de la UNAM;Mar/Abr2012, Vol. 55 Issue 2, p44 

    No abstract available.

  • Proportion of Invasive Pneumococcal Infections in German Children Preventable by Pneumococcal Conjugate Vaccines. Von Kries, R &uumi; diger; Siedler, Anette; Schmitt, Heinz J.; Reinert, Ralf Ren é // Clinical Infectious Diseases;8/1/2000, Vol. 31 Issue 2, p482 

    Deals with a study which investigated the incidence and serotype distribution of Streptococcus pneumoniae as a cause of invasive diseases of children in Germany from January 1997 through December 1998. Variation on the magnitude of impact of a conjugate pneumococcal vaccine; Clinical process...

  • Serotype-independent pneumococcal vaccines. Miyaji, Eliane; Oliveira, Maria; Carvalho, Eneas; Ho, Paulo // Cellular & Molecular Life Sciences;Sep2013, Vol. 70 Issue 18, p3303 

    Streptococcus pneumoniae remains an important cause of disease with high mortality and morbidity, especially in children and in the elderly. The widespread use of the polysaccharide conjugate vaccines in some countries has led to a significant decrease in invasive disease caused by vaccine...

  • Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods. Johansson, Niclas; Kalin, Mats; Tiveljung-Lindell, Annika; Giske, Christian G.; Hedlund, Jonas // Clinical Infectious Diseases;1/15/2010, Vol. 50 Issue 2, p202 

    Background. The microbial etiology of community-acquired pneumonia (CAP) is still not well characterized. During the past few years, polymerase chain reaction (PCR)-based methods have been developed for many pathogens causing respiratory tract infections. The aim of this study was to determine...

  • One-Step Multiplex PCR Assay for Detecting Streptococcus pneumoniae Serogroups/Types Covered by 13-Valent Pneumococcal Conjugate Vaccine (PCV13). Coskun-Ari, Fatma Filiz; Guldemir, Dilek; Durmaz, Riza // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    The life-threatening illnesses caused by Streptococcus pneumoniae have been declined significantly after the use of pneumococcal conjugate vaccines. Continuous monitoring of the vaccine serogroups/types is necessary to follow the changing epidemiology of invasive pneumococcal diseases. Recently,...


Read the Article


Sign out of this library

Other Topics